Montea Comm. VA (EBR:MONT)

Revance Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,535	1,459	1,579	1,094	2,144	1,492
Market Cap Growth	-9.09%	-7.58%	44.37%	-48.98%	43.70%	16.69%
Enterprise Value	2,613	2,370	2,408	1,985	2,719	1,966
Last Close Price	66.70	60.72	79.30	59.45	115.57	79.69
PE Ratio	8.22	8.51	13.32	5.35	9.41	9.62
PS Ratio	10.72	10.63	12.10	9.85	22.70	18.06
PB Ratio	0.84	0.81	1.04	0.84	2.11	1.83
P/OCF Ratio	11.91	12.62	14.10	12.95	29.16	21.29
EV/Sales Ratio	18.25	17.27	18.45	17.88	28.79	23.81
EV/EBITDA Ratio	22.80	21.70	23.35	21.71	35.03	28.96
EV/EBIT Ratio	22.87	21.77	23.43	21.81	35.19	29.07
Debt / Equity Ratio	0.60	0.55	0.56	0.72	0.66	0.66
Debt / EBITDA Ratio	9.54	9.10	8.26	10.20	8.61	7.95
Asset Turnover	-	0.05	0.06	0.05	0.06	0.06
Quick Ratio	0.16	0.66	1.28	0.92	0.33	0.28
Current Ratio	0.68	0.79	1.32	0.95	0.35	0.36
Return on Equity (ROE)	10.51%	10.32%	8.42%	17.64%	24.88%	20.73%
Return on Assets (ROA)	-	2.56%	2.70%	2.79%	3.06%	3.26%
Return on Capital (ROIC)	2.69%	2.63%	2.79%	2.90%	3.18%	3.37%
Earnings Yield	11.49%	11.75%	7.51%	18.70%	10.62%	10.39%
Dividend Yield	5.65%	6.16%	4.72%	5.55%	2.62%	3.55%
Payout Ratio	42.82%	44.04%	49.97%	24.01%	19.90%	25.84%
Buyback Yield / Dilution	-14.89%	-14.24%	-11.18%	-2.53%	-1.35%	-4.51%
Total Shareholder Return	-9.24%	-8.08%	-6.47%	3.02%	1.27%	-0.96%

Updated Feb 11, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.